Quality control and clinical application of two bone imaging 99mTc radiopharmaceuticals

被引:4
|
作者
Ayranov, M [1 ]
Strezov, A
Jordanova, A
Piperkova, E
Sergieva, S
机构
[1] Bulgarian Acad Sci, Inst Nucl Res & Nucl Energy, Sofia, Bulgaria
[2] Natl Oncol Ctr, BU-1157 Sofia, Bulgaria
关键词
Chromatography; Nuclear Medicine; Clinical Application; Complex Formation; Thin Layer Chromatography;
D O I
10.1007/BF02349177
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The radiochemical purity of MDP and HEDP has been determined by means of gel chromatography on Sephadex and thin layer chromatography on plastic foil silica gel. The comparison of the two radiopharmaceuticals shows equal level of complex formation with Tc-99m. The biodistribution demonstrated that the application of HEDP allows earlier scanning than MDP. MDP and HEDP show equal effectivity during the clinical investigations. There is no significant difference in the radiochemical purity within six hours after the reconstitution of the freeze-dried kits. HEDP kit demonstrates shorter period of accumulation and equivalent complex formation levels, so it can be used in routine nuclear medicine diagnostics together with MDP kit.
引用
收藏
页码:349 / 352
页数:4
相关论文
共 50 条
  • [1] Quality control and clinical application of two bone imaging99mTc radiopharmaceuticals
    M. Ayranov
    A. Strezov
    A. Jordanova
    E. Piperkova
    S. Sergieva
    Journal of Radioanalytical and Nuclear Chemistry, 1999, 240 : 349 - 352
  • [2] Comparative quality control of some bone-seeking 99mTc radiopharmaceuticals by gel chromatography
    Vinca Institute of Nuclear Sciences, Laboratory for Radioisotopes, P.O. Box 522, 11001 Belgrade, Yugoslavia
    J. RADIOANAL. NUCL. CHEM., 4 (291-298):
  • [3] Deficiencies in product labelling instructions and quality control directions for 99mTc radiopharmaceuticals
    Buroni, Federica E.
    Lodola, Lorenzo
    Persico, Marco G.
    Aprile, Carlo
    NUCLEAR MEDICINE COMMUNICATIONS, 2014, 35 (02) : 197 - 204
  • [4] The influence of carrier on 99mTc radiopharmaceuticals
    Ballinger, JR
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE, 2002, 46 (03): : 224 - 232
  • [5] Coordination chemistry for 99mTc radiopharmaceuticals
    Feng Cuilan
    Wang Mouhua
    Cheng Kangmin
    Shen Yumei
    PROGRESS IN CHEMISTRY, 2006, 18 (12) : 1615 - 1625
  • [6] Advances in the use of 99mTc radiopharmaceuticals in Russia
    Kodina, GE
    Korsunskii, VN
    RADIOCHEMISTRY, 1997, 39 (05) : 385 - 388
  • [7] Influence of 99Tc in the preparation of 99mTc radiopharmaceuticals
    Urbano, Nicoletta
    Modoni, Sergio
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (05) : 521 - 522
  • [8] Quality control of 99mTc-radiopharmaceuticals: assessing our clinical practice
    Machado, Joana do Mar Ferreira
    Tegala, Ronan
    Gibson, Vicky
    Edmonds, Scott
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S105 - S106
  • [9] Influence of 99Tc in the Preparation of 99mTc Radiopharmaceuticals
    Urbano, N.
    Modoni, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S354 - S354
  • [10] Imaging study of using radiopharmaceuticals labeled with cyclotron-produced 99mTc
    Hou, X.
    Tanguay, J.
    Vuckovic, M.
    Buckley, K.
    Schaffer, P.
    Benard, F.
    Ruth, T. J.
    Celler, A.
    PHYSICS IN MEDICINE AND BIOLOGY, 2016, 61 (23): : 8199 - 8213